VAI |
---|
PAD | Quartile 1 (< 0.84) | Quartile 2 (0.84 to < 1.36) | Quartile 3 (1.36 to < 2.25) | Quartile 4 (≥ 2.25) | P for trend |
---|
Participants, n | 1654 | 1653 | 1654 | 1654 | Â |
Cases, n | 47 (2.84%) | 54 (3.27%) | 66 (3.99%) | 45 (2.72%) | Â |
Model 1 | Reference | 1.39 (0.92, 2.09) | 2.13 (1.42, 3.20) | 1.83 (1.16, 2.89) | 0.001 |
Model 2 | Reference | 1.56 (1.03, 2.37) | 2.50 (1.64, 3.80) | 2.29 (1.42, 3.68) |  < 0.001 |
Model 3 | Reference | 1.64 (1.02, 2.64) | 2.27 (1.39, 3.72) | 2.22 (1.27, 3.90) | 0.002 |
Model 4 | Reference | 1.49 (0.92, 2.44) | 1.95 (1.14, 3.32) | 1.93 (1.04, 3.57) | 0.030 |
- Values are ORs (95% CIs) unless otherwise indicated. PAD, peripheral arterial disease; VAI, visceral adiposity index
- Model 1 was adjusted for age, sex
- Model 2 was adjusted for age, sex, BMI, SBP, DBP
- Model 3 was adjusted for age, sex, BMI, SBP, DBP, diabetes mellitus, stroke, CHD, antihypertensive drugs, lipoprotein-lowering drugs, glucose-lowering drugs, current smoking, current drinking, education, physical activity
- Model 4 was adjusted for age, sex, BMI, SBP, DBP, diabetes mellitus, stroke, CHD, antihypertensive drugs, lipoprotein-lowering drugs, glucose-lowering drugs, current smoking, current drinking, education, physical activity, Hcy, FBG, TC, LDL, eGFR, serum aspartate aminotransferase, serum alanine aminotransferase, serum γ-glutamyltransferase